title: Evaluation of adrenomedullin levels in renal parenchyma subjected to extracorporeal shockwave lithotripsy.
abstract: Despite its safety and efficacy, the traumatic effects of high-energy shock waves (HESW) on renal morphology and function during long-term follow-up have yet to be elucidated. Although the main target of shock waves is the stone located in the kidney, the surrounding tissue and other organs are also subjected to trauma during this procedure. In contrast to renal blood flow evaluation after shock wave treatment, ischemic development, causing varying degrees of damage at the tissue level, has not been well evaluated. The renoprotective peptide adrenomedullin (AM) is a potent vasorelaxing, natriuretic and cell growth modulating peptide, which is thought to act as an autocrine/paracrine regulator in renal glomeruli and tubules. In this experimental study, renal parenchymal AM levels were assessed in an attempt to evaluate the effect of HESW on the tissue levels of this peptide, which may be responsible for the regulation of ischemia induced by extracorporeal shock wave lithotripsy(ESWL), in a rabbit model. Thirty white New Zealand rabbits, each weighing 3-5 kg were used. The animals were divided into three main groups, and varying numbers of shock waves (1000, 1500, 2000) were applied under fluoroscopic localization to the same kidney of all animals. Ketamine HCl anesthesia was administered (15-20 mg/kg) and all of the procedures were performed with a Multimed 2000 lithotriptor. Untreated contralateral kidneys were evaluated as controls. Following HESW application, the treated and untreated kidneys of each animal were removed through bilateral flank incisions under ketamine HCl anesthesia after 24 h and 7 days, respectively. Tissue AM levels were assessed with immunohistochemistry. During the early follow-up period (24 h), both treated and untreated kidneys showed a moderate to high degree of AM positivity. The number of tubules stained with AM increased as the number of shock waves increased and the expression of this protein became evident, possibly due to a higher degree of tissue damage. Additionally, a limited degree of AM positivity was noted in the contralateral kidneys although this was not as evident as the positivity seen in the treated kidneys. Assessment of tissue AM levels during late follow-up (7 days) in both kidneys demonstrated a moderate or limited degree of positivity in the treated kidneys. Limited or no positivity could be demonstrated in the contralateral kidneys at this time. Taking the certain traumatic effects of HESW, which causes transient ischemia during ESWL, into account, we conclude that the application of HESW results in a transient decrease in renal perfusion, causing ischemic injury in treated as well as in contralateral (untreated) kidneys. This ischemic event lasts for a short time and seemed to be dose- and time-dependent. Increased tissue levels of AM appear to be a potential defence against ESWL induced ischemia.
authors.affiliation: Department of Urology, Sahinbey Medical Center, University of Gaziantep, Medical School, 27070 Kolejtepe/Gaziantep, Turkey. Kemalsarica@superonline.com
authors.forename: Kemal
authors.initials: K
authors.lastname: Sarica
authors.forename: Ibrahim
authors.initials: I
authors.lastname: Sari
authors.forename: Ayşe
authors.initials: A
authors.lastname: Balat
authors.forename: Ahmet
authors.initials: A
authors.lastname: Erbağci
authors.forename: Cihanser
authors.initials: C
authors.lastname: Yurtseven
authors.forename: Faruk
authors.initials: F
authors.lastname: Yağci
authors.forename: Metin
authors.initials: M
authors.lastname: Karakök
mesh_terms: D053607:Adrenomedullin; D000818:Animals; D007511:Ischemia / Q000209:etiology / Q000378:metabolism; D007668:Kidney / Q000293:injuries / Q000378:metabolism*; D007674:Kidney Diseases / Q000209:etiology / Q000378:metabolism; D008096:Lithotripsy / Q000009:adverse effects*; D010455:Peptides / Q000378:metabolism*; D011817:Rabbits; D012079:Renal Circulation
chemical_list: D010455:Peptides; D053607:Adrenomedullin